Clinical trial
Evaluation of Trimethylamine N-oxide (TMAO) Levels in Periodontal Disease
NCT06906510 is registered in ClinicalTrials.gov with Ankara Medipol University as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Evaluation of Trimethylamine N-oxide (TMAO) Levels in Periodontal Disease
- Lead sponsor
- Ankara Medipol University
- Phase
- Observational
- Overall status
- Completed
- Start date
- January 8, 2024
- Completion date
- September 23, 2024
- Enrollment
- 48 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
inflammation, periodontitis, tnf-alfa, trimethylamine n-oxide (tmao)